Societal perspectives analysis for evaluating direct-acting antiviral affordability while awaiting liver transplant
Hepatology
.
2018 Jan;67(1):450.
doi: 10.1002/hep.29558.
Authors
Xibei Liu
1
,
Yousif Elmofti
2
,
Catherine Kulaga
3
,
Brandon Gisi
3
,
Ji Won Yoo
2
Affiliations
1
Department of Medicine, University of Arizona College of Medicine, Tucson, AZ.
2
Department of Internal Medicine, University of Nevada Las Vegas School of Medicine, Las Vegas, NV.
3
University of Nevada Reno School of Medicine, Reno, NV.
PMID:
28960417
DOI:
10.1002/hep.29558
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents*
Hepacivirus
Humans
Liver Transplantation*
Substances
Antiviral Agents